Investors/Media

Investors / Media

Stock price graph
     

Infinity Pharmaceuticals, Inc. is an innovative drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult to treat diseases. Infinity Pharmaceuticals, Inc. combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity Pharmaceuticals, Inc.'s programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositol-3-kinase (PI3-kinase) are evidence of its innovative approach to drug discovery and development.

View all »Events

Jan 27, 2012 at 8:30 AM ET
Saridegib Update


Annual Report


Click here to view the 2010 Annual Report PDF


View all »   RSSRecent Releases

Sep 12, 2011
Infinity Pharmaceuticals to Present at UBS Conference

Aug 30, 2011
Infinity Pharmaceuticals to Present at Two Upcoming Conferences

Stock Quote (NASDAQ: INFI)
Price:
6.95
Change:
+ 0.49
Day High:
6.95
Day Low:
6.48
Volume:
176,400
4:00 PM ET on Feb 3, 2012
Delayed at least 20 minutes.
Provided by eSignal.